Clinical Trial

Intra-articular Corticosteroid Injection in GAE for Knee Knee Osteoarthritis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to investigate the effectiveness and safety of intra-articular corticosteroid injection (IACI) in alleviating post-procedural pain and improving early outcomes in patients undergoing geniculate artery embolization (GAE) for knee osteoarthritis (OA). The main questions it aims to answer are: * Does intra-articular corticosteroid injection reduce pain levels post-procedure compared to GAE alone? * Does the combination of GAE and IACI improve functional outcomes and patient-reported outcomes compared to GAE alone? Investigators will compare patients receiving GAE with IACI to those receiving GAE alone to see if the addition of IACI provides superior pain relief and functional improvement. Participants will: * Undergo geniculate artery embolization, with or without intra-articular corticosteroid injection. * Have their pain levels assessed using the Visual Analog Scale (VAS) at 1 week, 2 weeks, and 4 weeks post-procedure. * Complete functional outcome assessments using the KOOS and WOMAC scores. * Report any adverse events throughout the study period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-17.
Status change: Not Yet Recruiting → Recruiting 2024-09-29
Trial Details
NCT Number NCT06514716
Lead Sponsor Zagazig University
Conditions Knee Osteoarthritis, Pain, Musculoskeletal
Enrollment 60 participants
Start Date 2024-09-29
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-01